Stock Market News

Feb 17, 2017 - 1:56 PM

Celgene Higher Off Positive Phase II Sunbeam Trial Of Oral Ozanimod

Celgene Corporation (NASDAQ: CELG) shares are trading higher by $2.00 at $120.66 in Friday's session. The catalyst for the rally is a Phase II study of Oral Ozanimod with relapsing MS meeting its primary endpoint in reducing ARR, measured endpoints....
read full stock news story
Feb 17, 2017 - 1:54 PM

Will Kroger Get Dragged Into The Amazon, Wal-Mart E-Commerce Conflict?

In a note released on Friday, Oppenheimer delved on whether the Amazon.com, Inc. (NASDAQ: AMZN) versus Wal-Mart Stores Inc (NYSE: WMT) e-commerce battle will bring Kroger Co (NYSE: KR) into the fray....
read full stock news story
Feb 17, 2017 - 1:50 PM

UnitedHealth Lower Off NYT Article Claiming Suit For Overbilling Medicare

UnitedHealth Group Inc (NYSE: UNH) shares are trading lower by $6.50 (4 percent) at $157.13 in Friday's session. Investors are exiting the issue after an article appeared in The New York Times regarding a lawsuit that says the company overbilled Medicare for years....
read full stock news story
Feb 17, 2017 - 1:41 PM

IBM and Tech 'Dinosaurs' Still Alive and Well

I would buy either IBM or HPE on a dip....
read full stock news story
Feb 17, 2017 - 1:38 PM

Clovis, Tesaro Soar on Astrazeneca Phase Three News

AstraZeneca shares, meanwhile, were less-than-moved by the news....
read full stock news story
Displaying 46 - 50 of 100



Make a suggestion for this page